Author: Michael Jay Corley; Christopher Sugai; Michael Schotsaert; Robert E. Schwartz; Lishomwa C Ndhlovu
Title: Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes. Document date: 2020_4_14
ID: 30x26ip7_21
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.13.039263 doi: bioRxiv preprint biosynthetic process, GO molecular function chemokine activity, and GO cellular component integral component of plasma membrane (Fig.3a-c, Supplemental Data 1) . Specifically, HCQ altered expression of LDLR, CXCL6, CCL18, CCL5, and CXCL3 genes (Fig.3d-h) . To extend our findings of HCQ impacting immune chem.....
Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.13.039263 doi: bioRxiv preprint biosynthetic process, GO molecular function chemokine activity, and GO cellular component integral component of plasma membrane (Fig.3a-c, Supplemental Data 1) . Specifically, HCQ altered expression of LDLR, CXCL6, CCL18, CCL5, and CXCL3 genes (Fig.3d-h) . To extend our findings of HCQ impacting immune chemokine activity in innate immune cells, we examined transcriptomes of plasmacytoid dendritic cells (pDC) from four healthy individuals that had been either stimulated with RNA-IC for 6 hours only or stimulated with RNA-IC for 6 hours in the presence of HCQ (Supplementary Table 1) . We observed that CXCL10, CXCL11, CCL4, and CXCL9 genes were significantly downregulated in stimulated HCQ treatment compared to the only stimulated condition (Supplemental Figure 4) . Together, our findings in macrophages and pDC cells suggest HCQ impacts certain cell type specific chemokine signaling pathways and likely modulates immune inflammation.
Search related documents:
Co phrase search for related documents- biosynthetic process and HCQ treatment: 1
- biosynthetic process and integral component: 1
- biosynthetic process and molecular function: 1
- cell type and dendritic cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
- cell type and HCQ treatment: 1
- cell type and healthy individual: 1
- cell type and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- cell type and immune inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- cell type and innate immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- cell type and molecular function: 1, 2
- cell type and pDC plasmacytoid dendritic cell: 1
- cell type and plasma membrane: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- cell type and plasmacytoid dendritic cell: 1, 2, 3, 4, 5, 6, 7
- cell type and Supplementary table: 1, 2, 3, 4, 5, 6, 7, 8, 9
- chemokine activity and HCQ treatment: 1, 2
- chemokine activity and immune cell: 1, 2, 3, 4, 5
- chemokine activity and immune inflammation: 1, 2, 3
- chemokine activity and molecular function: 1
- chemokine activity and molecular function chemokine activity: 1
Co phrase search for related documents, hyperlinks ordered by date